Compare GSK plc (GSK) vs Rollins Inc. Common Stock (ROL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs Rollins Inc. Common Stock — how do they compare? GSK plc trades at $49.11 (market cap $96.45B), while Rollins Inc. Common Stock trades at $33.02 (market cap $15.70B). The key difference: GSK plc is far larger — about 6.1× Rollins Inc. Common Stock's market cap, and GSK plc pays the higher dividend (3.79%). Which is the better fit depends on your goals — on Pluang, investors hold GSK plc for 93 Days and Rollins Inc. Common Stock for 0 Days on average.
| GSK | ROL | |
|---|---|---|
Market Cap | $96.45B | $15.70B |
Volume | 7,087,457 | 4,855,082 |
Sector | Health | Industrials |
52-Week High | $61.18 | $65.60 |
52-Week Low | $43.24 | $29.69 |
Typical Hold Time | 93 Days | 0 Days |
Enterprise Value | $116.51B | $16.71B |
Dividend Yield | 3.79% | 2.24% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK trades at $46.27, down 1.39% today, with a bearish technical signal from moving averages. The company shows strong profitability with a 72.73% gross margin and 14.52% net margin, supported by recent earnings beats. Analysts are mixed with 31% buy ratings, while recent news highlights strategic oncology investments and a $750M deal for a cancer therapy.
GSK's outlook is balanced by solid fundamentals against near-term headwinds. Investment appeal lies in its high margins and pipeline growth, but risks include patent expirations and competitive pressures. The stock offers value with a P/E of 15.38, though technical weakness suggests cautious entry points.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About Rollins Inc. Common Stock
Rollins Inc. provides pest control services to residential and commercial customers through its family of brands, including Orkin, across dozens of countries.
Read more on ROL →
